
SetPoint Medical's system reached patients in Southern New Jersey, where the Global Neurosciences Institute performed its first procedures for rheumatoid arthritis. SetPoint's implant, the first FDA-approved neuroimmune modulation therapy, stimulates the vagus nerve to activate anti-inflammatory pathways.